Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: A meta-analysis in the highly active antiretroviral therapy era

European Heart Journal

Volumn 34, Issue 19, 2013, Pages 1432-1436

  Cerrato, Enrico ^a   D'Ascenzo, Fabrizio ^a   Biondi Zoccai, Giuseppe ^b   Calcagno, Andrea ^c   Frea, Simone ^a   Grosso Marra, Walter ^a   Castagno, Davide ^a   Omedè, Pierluigi ^a   Quadri, Giorgio ^a   Sciuto, Filippo ^a   Presutti, Davide ^a   Frati, Giacomo ^b   Bonora, Stefano ^c   Moretti, Claudio ^a   Gaita, Fiorenzo ^a  

^a Azienda Ospedaliera Città della Salute e della Scienza   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

Antiretroviral therapy; Echocardiography; HAART; Heart failure; HIV

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; ASYMPTOMATIC DISEASE; CARDIAC IMAGING; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; MEDICAL HISTORY; META ANALYSIS; PRIORITY JOURNAL; SMOKING; SYSTEMATIC REVIEW; SYSTOLE; TREATMENT DURATION;

ANTIRETROVIRAL THERAPY; ECHOCARDIOGRAPHY; HAART; HEART FAILURE; HIV;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEART DISEASES; HIV INFECTIONS; HUMANS; MIDDLE AGED; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84877005066     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs471     Document Type: Article

References (55)

1. Lewis W. Cardiomyopathy in AIDS: a pathophysiological perspective. Prog Cardiovasc Dis 2000;43:151.
2. Sani MU. Myocardial disease in human immunodeficiency virus (HIV) infection: a review. Wien Klin Wochenschr 2008;120:77.
3. D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I. Acute coronary syndromes in human immunodeficiency virus patients: a meta analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J 2012;33:875-880.
4. Biondi-Zoccai G, D'Ascenzo F, Modena MG. Novel insights on HIV/AIDS and cardiac disease: shedding light on the HAART of Darkness. Eur Heart J 2012; 33:813-815
5. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994;24:1025-1032.
6. De Castro S, d'Amati G, Gallo P, Cartoni D, Santopadre P, Vullo V, Cirelli A, Migliau G. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol 1994;24:1018.
7. Fink L, Reichek N, Sutton MG. Cardiac abnormalities in acquired immune deficiency syndrome. Am J Cardiol 1984;54:1161.
8. Levy WS, Simon GL, Rios JC, Ross AM. Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989;63:86-89.
9. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993;71:955.
10. Barbaro G. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy. Curr Drug Targets Cardiovasc Haematol Disord 2005;5:337.
11. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.
12. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354: 1896-900.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
14. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochranehandbook.org.
15. DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-1735.
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group. American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. J Am Soc Echocardiogr 2005;18:1440-1463.
17. Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, McKiddie F, O'Connor M, Prvulovich E, Underwood R, van Eck-Smit B; EANM/ESC Group. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855-897.
18. Choi AI, Vittinghoff E, Deeks SG, Weekley CC, Li Y, Shlipak MG. Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS 2011;25:1289-1298.
19. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee S, Nelson KE, Tong W, Lai S. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 2002; 30:306-310.
20. Oliviero U, Bonadies G, Bosso G, Foggia M, Apuzzi V, Cotugno M, Valvano A, Leonardi E, Borgia G, Castello G, Napoli R, Saccà L. Impaired diastolic function in näive untreated human immunodeficiency virus infected patients. World J Cardiol 2010;26:98-103.
21. Roy VP, Prabhakar S, Pulvirenti J, Mathew J. Frequency and factors associated with cardiomyopathy in patients with human immunodeficiency virus infection in an inner-city hospital. J Natl Med Assoc 1999;91:502-504.
22. Lai H, Redheuil A, Tong W, Bluemke DA, Lima JA, Ren S, Lai S. HIV infection and abnormal regional ventricular function. Int J Cardiovasc Imaging 2009;25:809-817.
23. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000;40:282-284.
24. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail 2010;3:132-139.
25. Luo L, Ye Y, Liu Z, Zuo L, Li Y, Han Y, Qiu Z, Li L, Zeng Y, Li TS. Assessment of cardiac diastolic dysfunction in HIV-infected people without cardiovascular symptoms in China. Int J STD AIDS 2010;21:814-818.
26. Nayak G, Ferguson M, Tribble DR, Porter CK, Rapena R, Marchicelli M, Decker CF. Cardiac diastolic dysfunction is prevalent in HIV-infected patients. AIDS Patient Care STDS 2009;23:231-238.
27. Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T; German Competence Network for Heart Failure; German Competence Network for HIV AIDS. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials 2010;11: 156-162.
28. Bijl M, Dieleman JP, Simoons M, van der Ende ME. Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy. J Acquir Immune Defic Syndr 2001;27:318-320.
29. El Hattaoui M, Charei N, Boumzebra D, Aajly L, Fadouach S. Prevalence of car-diomyopathy in HIV infection: prospective study on 158 HIV patients. Médecine et maladies infectieuses 2008;38:387-391.
30. Karavidas A, Tsiachris D, Lazaros G, Xylomenos G, Arapi S, Potamitis N, Matzaraki V, Caplanis J, Matsakas E, Gargalianos P, Pyrgakis V, Stefanadis C. Doppler tissue imaging unmasks right ventricular function abnormalities in HIV-infected patients. Cardiol J 2010;17:587-593.
31. Schuster I, Thöni GJ, Edérhy S, Walther G, Nottin S, Vinet A, Boccara F, Khireddine M, Girard PM, Mauboussin JM, Rouanet I, Dauzat M, Cohen A, Messner-Pellenc P, Obert P. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol 2008; 101:1213-1217.
32. Mondy KE, Gottdiener J, Overton ET, Henry K, Bush T, Conley L, Hammer J, Carpenter CC, Kojic E, Patel P, Brooks JT; SUN Study Investigators. High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy. Clin Infect Dis 2011;52:378-386.
33. Kristoffersen US, Lebech AM, Gerstoft J, Hesse B, Petersen CL, Gutte H, Kjaer A. Right and left cardiac function in HIV-infected patients investigated using radio-nuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study. HIV Med 2008;9:180-186.
34. Lebech AM, Gerstoft J, Hesse B, Petersen CL, Kjaer A. Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography. Am Heart J 2004;147:482-488.
35. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomy-opathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-1099.
36. Karavidas A, Foukarakis M, Lazaros G, Chini M, Fotiadis I, Arapi S, Gialernios T, Potamitis N, Gargalianos P, Matsakas E, Stefanadis C. Assessment of cardiac function with Doppler tissue imaging in asymptomatic HIV-infected patients. Int J STD AIDS 2008;19:227-231.
37. Mittal CM, Wig N, Mishra S, Arora P, Pandey RM. Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India. Int J Cardiol 2006;107: 136-137.
38. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha Gonçalves F, Lecour H. Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. Int J Cardiol 1998;63:37.
39. Schuster I, Thöni GJ, Edérhy S, Walther G, Nottin S, Vinet A, Boccara F, Khireddine M, Girard PM, Mauboussin JM, Rouanet I, Dauzat M, Cohen A, Messner-Pellenc P, Obert P. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol 2008; 101:1213.
40. Kavanaugh-McHugh AL, Ruff A, Perlman E, Hutton N, Modlin J, Rowe S. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. J Parenter Enteral Nutr 1991;15:347-349.
41. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, Shor-Posner G, Skyler JS, Schneiderman N. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 2007;167:148-154.
42. Rodriguez ER, Nasim S, Hsia J, Sandin RL, Ferreira A, Hilliard BA, Ross AM, Garrett CT. Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: detection by multiplex, nested, polymerase chain reaction in individually microdissected cells from right ventricular endomyocardial biopsy tissue. Am J Cardiol 1991;68: 1511-1520.
43. Herskowitz A, Willoughby S, Wu TC, Beschorner WE, Neumann DA, Rose NR, Baughman KL, Ansari AA. Immunopathogenesis of HIV-1-associated cardiomyop-athy. Clin Immunol Immunopathol 1993;68:234.
44. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002; 1:329.
45. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 2007;5:129.
46. Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC. Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol 1991;17:1270-1276.
47. Arinola OG, Adedapo KS, Kehinde AO, Olaniyi JA, Akiibinu MO. Acute phase proteins, trace elements in asymptomatic human immunodeficiency virus infection in Nigerians. Afr J Med Med Sci 2004;33:317-322.
48. Noursadeghi M, Miller RF. Clinical value of C-reactive protein measurements in HIV-positive patients. Int J STD AIDS 2005;16:438-441.
49. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009; 51:268-273.
50. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg 2007;31:632-643.
51. Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998;98:450.
52. Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU. Transgenic expression of replication-restricted entero-viral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 1998;102:1444.
53. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardio-myopathy. Circ Res 1994;74:182.
54. Keeling PJ, Tracy S. Link between enteroviruses and dilated cardiomyopathy: sero-logical and molecular data. Br Heart J 1994;72:S25.
55. Agostoni P, Kedhi E, Verheye S, Vermeersch P, Van Langenhove G. Dissimilar relevance given to diseases by medical literature, and the potential to create biases in the clinical decision-making process: The case of late stent thrombosis. Int J Cardiol 2007;114:E38-E39.